Hepatitis Monthly

Published by: Kowsar

The Effect of Octreotide on Urine Output During Orthotopic Liver Transplantation and Early Postoperative Renal Function; A Randomized, Double-Blind, Placebo-Controlled Trial

Mohammad Ali Sahmeddini 1 , * , Afshin Amini 1 and Nima Naderi 1
Authors Information
1 Shiraz Anesthesiology and Intensive Care Research Center, Shiraz University of Medical Science, Shiraz, IR Iran
Article information
  • Hepatitis Monthly: September 01, 2013, 13 (9); e12787
  • Published Online: September 18, 2013
  • Article Type: Research Article
  • Received: June 10, 2013
  • Revised: July 31, 2013
  • Accepted: August 21, 2013
  • DOI: 10.5812/hepatmon.12787

To Cite: Sahmeddini M A, Amini A, Naderi N. The Effect of Octreotide on Urine Output During Orthotopic Liver Transplantation and Early Postoperative Renal Function; A Randomized, Double-Blind, Placebo-Controlled Trial, Hepat Mon. 2013 ; 13(9):e12787. doi: 10.5812/hepatmon.12787.

Abstract
Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Junge G, Schewior LV, Kohler S, Neuhaus R, Langrehr JM, Tullius S, et al. Acute renal failure after liver transplantation: incidence, etiology, therapy, and outcome. Transplant Proc. 2006; 38(3): 723-4[DOI][PubMed]
  • 2. O'Riordan A, Wong V, McQuillan R, McCormick PA, Hegarty JE, Watson AJ. Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation. Am J Transplant. 2007; 7(1): 168-76[DOI][PubMed]
  • 3. Steadman RH, Csete M. Complications of liver transplantation. Seminars in Anesthesia, Perioperative Medicine and Pain. 1996; 15(3): 250-5[DOI]
  • 4. Lewandowska L, Matuszkiewicz-Rowinska J. Acute kidney injury after procedures of orthotopic liver transplantation. Ann Transplant. 2011; 16(2): 103-8[PubMed]
  • 5. Rueggeberg A, Boehm S, Napieralski F, Mueller AR, Neuhaus P, Falke KJ, et al. Development of a risk stratification model for predicting acute renal failure in orthotopic liver transplantation recipients. Anaesthesia. 2008; 63(11): 1174-80[DOI][PubMed]
  • 6. Fonseca-Neto OCLD, Miranda LEC, Melo PS, Sabat BD, Amorim AG, Lacerda CM. Predictors of acute kidney injury in patients undergoing a conventional orthotopic liver transplant without veno-venous bypass. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 2011; 24(2): 152-158
  • 7. Lima EQ, Zanetta DM, Castro I, Massarollo PC, Mies S, Machado MM, et al. Risk factors for development of acute renal failure after liver transplantation. Ren Fail. 2003; 25(4): 553-60[PubMed]
  • 8. Steadman RH. Anesthesia for liver transplant surgery. Anesthesiol Clin North America. 2004; 22(4): 687-711[DOI][PubMed]
  • 9. Mandell MS, Katz JJ, Wachs M, Gill E, Kam I. Circulatory pathophysiology and options in hemodynamic management during adult liver transplantation. Liver Transplantation and Surgery. 1997; 3(4): 379-387[DOI]
  • 10. Planinsic RM, Lebowitz JJ. Renal failure in end-stage liver disease and liver transplantation. Int Anesthesiol Clin. 2006; 44(3): 35-49[DOI][PubMed]
  • 11. Betrosian AP, Agarwal B, Douzinas EE. Acute renal dysfunction in liver diseases. World J Gastroenterol. 2007; 13(42): 5552-9[PubMed]
  • 12. Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009; 361(13): 1279-90[DOI][PubMed]
  • 13. Schrier RW, Shchekochikhin D, Ginès P. Renal failure in cirrhosis: prerenal azotemia, hepatorenal syndrome and acute tubular necrosis. Nephrol Dial Transpl 2012; 27(7): 2625-8
  • 14. Arroyo V. Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy. Aliment Pharmacol Ther. 2004; 20 Suppl 3: 49-54[DOI][PubMed]
  • 15. Angeli P, Volpin R, Gerunda G, Craighero R, Roner P, Merenda R, et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology. 1999; 29(6): 1690-7[DOI][PubMed]
  • 16. Gluud LL, Christensen K, Christensen E, Krag A. Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology. 2010; 51(2): 576-84[DOI][PubMed]
  • 17. Angeli P, Merkel C. Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis. J Hepatol. 2008; 48 Suppl 1-103[DOI][PubMed]
  • 18. Cardenas A, Arroyo V. Renal and circulatory dysfunction in liver cirrhosis. Pathogenesis and treatment. Ann Gastroenterol 2007; 14(3)
  • 19. Wong F, Pantea L, Sniderman K. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology. 2004; 40(1): 55-64[DOI][PubMed]
  • 20. Kiser TH, Fish DN, Obritsch MD, Jung R, MacLaren R, Parikh CR. Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study. Nephrol Dial Transplant. 2005; 20(9): 1813-20[DOI][PubMed]
  • 21. Pomier-Layrargues G, Paquin SC, Hassoun Z, Lafortune M, Tran A. Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study. Hepatology. 2003; 38(1): 238-43[DOI][PubMed]
  • 22. Wiest R, Tsai MH, Groszmann RJ. Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats. Gastroenterology. 2001; 120(4): 975-83[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments